TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer

BACKGROUND: Drug resistance and recurrence are main contributors to the poor prognosis of ovarian cancer. Cisplatin is a platinum compound which is widely used in the treatment of various solid tumors including ovarian cancer. Up to now, the mechanism of cisplatin resistance in ovarian cancer is unc...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yixuan, Zhu, Keyu, Guan, Xiaolin, Xie, Suhong, Wang, Yanchun, Tong, Ying, Guo, Lin, Zheng, Hui, Lu, Renquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487155/
https://www.ncbi.nlm.nih.gov/pubmed/34598710
http://dx.doi.org/10.1186/s13048-021-00884-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487155/
https://www.ncbi.nlm.nih.gov/pubmed/34598710
http://dx.doi.org/10.1186/s13048-021-00884-z

Ejemplares similares